Parkinson's Disease Trial, Recruiting NCT07397377 Sponsor: Danish Research Centre for Magnetic Resonance Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT07397377
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older
  • You have been diagnosed with Parkinson's Disease (a condition affecting movement), confirmed by a specialist using recognised medical guidelines
  • Your Parkinson's medications have stayed the same for at least four weeks
  • You are willing and able to sign a consent form agreeing to take part

Who may not be able to join:

  • You have a psychiatric disorder (a mental health condition affecting thoughts, feelings, or behaviour)
  • You currently take antipsychotic medication, Donepezil (a memory medication), or certain nerve-calming medications such as pregabalin or gabapentin
  • You regularly use benzodiazepines (such as diazepam) or opioid painkillers more than once a week
  • You have a history of any neurological disease (a condition affecting the brain or nervous system) other than Parkinson's Disease
  • You have had, or currently have, a mental illness
  • You have a history of epilepsy or any condition that may increase the risk of seizures, particularly in relation to a brain stimulation technique called TMS (confirm with trial site)
  • A close family member has epilepsy or a condition linked to an increased risk of seizures
  • You have any medical reason why you cannot have an MRI scan (such as certain metal implants)
  • You have any medical reason why you cannot receive TMS, a type of non-invasive brain stimulation (confirm with trial site)
  • You are a woman of childbearing age who is pregnant, or who is not willing to use contraception during the trial
  • You are not willing to be told about any unexpected health-related findings discovered during the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 June 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Danish Research Centre for Magnetic Resonance
Registry
ClinicalTrials.gov
Start date
16 December 2025
Est. completion
1 May 2027

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Movement Disorder Society-Unified Parkinson's Disease Rating Scale Part III (3.4-3.8) (MDS-UPDRS-III); Modified Bradykinesia Rating Scale (MBRS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov